Esfenvalerate

Target genes for Esfenvalerate is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
EsfenvalerateNR1H3ATG_DR4_LXR_CIS_dn
EsfenvalerateNACEETOX_H295R_PROG_dn
EsfenvalerateCYP1A2CLD_CYP1A2_48hr
EsfenvalerateCYP2B6CLD_CYP2B6_48hr
EsfenvalerateCYP2B6CLD_CYP2B6_6hr
EsfenvalerateCYP2C19NVS_ADME_hCYP2C19
EsfenvalerateCYP3A4CLD_CYP3A4_48hr
EsfenvalerateCYP3A4CLD_CYP3A4_24hr
EsfenvalerateESR1ATG_ERa_TRANS_up
EsfenvalerateESRRATOX21_ERR_Antagonist
EsfenvalerateATF6TOX21_ESRE_BLA_ratio
EsfenvalerateBACE1NVS_ENZ_hBACE
EsfenvalerateNR3C1CEETOX_H295R_DOC_dn
EsfenvalerateNR3C1NVS_NR_hGR
EsfenvalerateHLA-DRABSK_3C_HLADR_down
EsfenvalerateHTR5ANVS_GPCR_h5HT5A
EsfenvalerateHTR7NVS_GPCR_h5HT7
EsfenvalerateCXCL8BSK_LPS_IL8_down
EsfenvalerateCXCL8BSK_SAg_IL8_down
EsfenvalerateARTOX21_AR_BLA_Antagonist_ratio
EsfenvalerateARTOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881
EsfenvalerateARACEA_AR_antagonist_80hr
EsfenvalerateNR3C2CEETOX_H295R_DOC_dn
EsfenvalerateMMP1BSK_hDFCGF_MMP1_up
EsfenvalerateMMP13NVS_ENZ_hMMP13
EsfenvalerateNFE2L2ATG_NRF2_ARE_CIS_up
EsfenvaleratePGRCEETOX_H295R_PROG_dn
EsfenvaleratePGRTOX21_PR_BLA_Antagonist_ratio
EsfenvaleratePGRCEETOX_H295R_OHPROG_dn
EsfenvaleratePGRCEETOX_H295R_OHPREG_dn
EsfenvaleratePLAURBSK_BE3C_uPAR_up
EsfenvaleratePOU2F1ATG_Oct_MLP_CIS_up
EsfenvalerateUGT1A1CLD_UGT1A1_48hr
EsfenvaleratePPARGATG_PPARg_TRANS_up
EsfenvaleratePTGER2BSK_LPS_PGE2_down
EsfenvalerateRARAATG_DR5_CIS_up
EsfenvalerateRARAATG_RARa_TRANS_up
EsfenvalerateRARBATG_DR5_CIS_up
EsfenvalerateRARGATG_DR5_CIS_up
EsfenvalerateRXRAATG_RXRa_TRANS_up
EsfenvalerateSELEBSK_SAg_Eselectin_down
EsfenvalerateSELEBSK_LPS_Eselectin_up
EsfenvalerateSLC6A3NVS_TR_hDAT
EsfenvalerateTACR2NVS_GPCR_hNK2
EsfenvalerateTHBDBSK_CASM3C_Thrombomodulin_up
EsfenvalerateTIMP2BSK_KF3CT_TIMP2_down
EsfenvalerateNR1H2ATG_DR4_LXR_CIS_dn
EsfenvalerateVCAM1BSK_4H_VCAM1_down
EsfenvalerateVDRATG_VDRE_CIS_up
EsfenvalerateCASP1NVS_ENZ_hCASP1
EsfenvalerateNR1I2ATG_PXRE_CIS_up
EsfenvalerateNR1I2ATG_PXR_TRANS_up
EsfenvalerateNR1I3TOX21_CAR_Antagonist
EsfenvalerateNR1I3ATG_PBREM_CIS_up
EsfenvalerateNR1H4TOX21_FXR_BLA_antagonist_ratio

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.